Outcomes of the Bethesda system for reporting thyroid cytopathology: Real‐life experience

Objective The 2017 revised Bethesda System for Reporting Thyroid Cytopathology (BSRTC) included new malignancy rates for each category as well as new management recommendations. Here, we evaluate the malignancy rate and test performance for BSRTC categories in a middle‐sized institution outside the United States (US). Design Retrospective single centre case series with chart review. Patients All patients who underwent thyroid surgery with a...